Pre and post treatment mucociliary function in allergic rhinitis in three different treatment modalities

Area of Science:

• Otolaryngology
• Allergology
• Pharmacology

Background:

• Allergic rhinitis negatively impacts nasal mucociliary function.
• Restoring mucociliary function is a key treatment goal for perennial allergic rhinitis.
• Understanding treatment effects on mucociliary transport time is crucial.

Purpose of the Study:

• To compare the efficacy of three treatment modalities on mucociliary transport time.
• To evaluate the impact of intranasal beclomethasone and loratadine on nasal mucociliary function in allergic rhinitis patients.

Main Methods:

• Ninety-two newly diagnosed allergic rhinitis patients were randomized into three groups.
• Treatment regimens included intranasal beclomethasone, a combination of beclomethasone and loratadine, or loratadine alone.
• Mucociliary transport time was measured before and after 8 weeks of treatment.

Main Results:

• A non-significant improvement in mucociliary function was observed in the group treated solely with intranasal beclomethasone.
• No significant changes in mucociliary transport time were noted in the groups receiving combination therapy or loratadine alone.
• Intranasal beclomethasone monotherapy showed a trend towards improved mucociliary function.

Conclusions:

• Intranasal beclomethasone monotherapy may offer a modest benefit for mucociliary function in allergic rhinitis.
• Combination therapy with loratadine or loratadine alone did not demonstrate significant effects on mucociliary transport time.
• Further research is needed to confirm the efficacy of intranasal corticosteroids in restoring nasal mucociliary function.